Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Participants With HR+/HER2- Metastatic Breast Cancer
Clinical trial NCT03901339 · COMPLETED
Trial details
- NCT number
- NCT03901339
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-08
- Primary completion
- 2023-10-20
- Enrollment
- 543
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.